Emvision Medical Devices Ltd (EMV.AX) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · Australia · ISIN AU0000028375

Price
1.42 AUD
Market cap
129.35 m AUD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
-52.74 %
Return on assets (ROA)
-36.10 %

Emvision Medical Devices Ltd financials

Fiscal year20252026
Revenue5.05 m AUD–
Gross profit5.05 m AUD-416,901.00 AUD
Operating income-8.13 m AUD-16.93 m AUD
EBIT-8.84 m AUD-16.93 m AUD
Net income-9.81 m AUD-8.32 m AUD
Diluted EPS – continuing operations-0.11 AUD-0.09 AUD

Full history since 2018, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Emvision Medical Devices Ltd

EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients. The company was incorporated in 2017 and is based in Macquarie Park, Australia.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.